Hanwool Kim

Title: Hanwool Kim: Innovator in Androgen Receptor Degradation

Introduction

Hanwool Kim is a notable inventor based in Ansan, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target androgen receptors. His innovative work has the potential to impact the treatment of various diseases related to androgen receptors.

Latest Patents

Hanwool Kim holds a patent for a substituted piperidine compound, which is described in detail as having the ability to degrade androgen receptors. The patent outlines a compound of Chemical Formula 1, where X is CR, or a pharmaceutically acceptable salt thereof. This compound is significant for its medical use in treating or preventing AR-related diseases. The patent also includes a method for administering an effective amount of the compound to subjects in need.

Career Highlights

Kim is currently associated with Ubix Therapeutics, Inc., where he continues to advance his research and development efforts. His work at Ubix Therapeutics focuses on innovative solutions for health challenges, particularly those involving androgen receptor pathways.

Collaborations

Some of his notable coworkers include Je Ho Ryu and Mi Young Jang. Their collaborative efforts contribute to the innovative environment at Ubix Therapeutics, fostering advancements in therapeutic solutions.

Conclusion

Hanwool Kim's contributions to the field of medicinal chemistry, particularly through his patent on substituted piperidines, highlight his role as an innovator in the treatment of AR-related diseases. His work at Ubix Therapeutics continues to pave the way for future advancements in this critical area of health.